Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma
Anticancer Research · 2024
DOI: 10.21873/anticanres.17151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ayaka Shimomura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan; shimomura.ayaka@kagawa-u.ac.jp. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Carcinoma, Pancreatic Ductal, Positron Emission Tomography Computed Tomography, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is reportedly associated with the malignant potential of cancer. This study aimed to evaluate the association between FDG accumulation and tumor metabolism in pancreatic ductal adenocarcinoma (PDAC). PATIENTS AND METHODS: A prognostic analysis of data from 131 patients with PDAC who underwent FDG-PET/CT before curative-intent pancreatic surgery was performed. Capillary electrophoresis-mass spectrometry (CE-MS) was used to analyze the metabolome of tumor and non-neoplastic pancreas from 80 patients. These patients were divided into two groups: low SUVmax group (SUVmax
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan; shimomura.ayaka@kagawa-u.ac.jp.
- Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan.
- Institute for Advanced Biosciences, Keio University, Kakuganji, Tsuruoka, Japan.
- Department of Hygiene, Kagawa University, Kagawa, Japan.
- Department of Radiology, Kagawa University, Kagawa, Japan.
Zitieren
APA
Shimomura, A., Oshima, M., Suto, H., Matsukawa, H., Kondo, A., Ando, Y., Kishino, T., Kumamoto, K., Sato, K., Sugimoto, M., Nagao, M., Miyatake, N., Norikane, T., Soga, T., & Okano, K. (2024). Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17151
Vancouver
Shimomura A, Oshima M, Suto H, Matsukawa H, Kondo A, Ando Y, et al. Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17151
BibTeX
@article{Shimomura2024,
author = {Shimomura, Ayaka and Oshima, Minoru and Suto, Hironobu and Matsukawa, Hiroyuki and Kondo, Akihiro and Ando, Yasuhisa and Kishino, Takayoshi and Kumamoto, Kensuke and Sato, Kiyotoshi and Sugimoto, Masahiro and Nagao, Mina and Miyatake, Nobuyuki and Norikane, Takashi and Soga, Tomoyoshi and Okano, Keiichi},
title = {Prognostic Significance of 18 F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17151}
}
EUVIMED